Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis
- PMID: 28243578
- PMCID: PMC5325720
- DOI: 10.1016/j.ijcme.2016.08.002
Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis
Abstract
Background/objectives: Cardiovascular (CV) risk is increased in patients with rheumatoid arthritis (RA), but not fully explained by traditional risk factors such as LDL and HDL cholesterol concentrations. The cholesterol efflux capacity of HDL may be a better CV risk predictor than HDL concentrations. We hypothesized that HDL's cholesterol efflux capacity is impaired and inversely associated with coronary atherosclerosis in patients with RA.
Methods: We measured the net cholesterol efflux capacity of apolipoprotein B depleted serum and coronary artery calcium score in 134 patients with RA and 76 control subjects, frequency-matched for age, race and sex. The relationship between net cholesterol efflux capacity and coronary artery calcium score and other clinical variables of interest was assessed in patients with RA.
Results: Net cholesterol efflux capacity was similar among RA (median [IQR]: 34% removal [28, 41%]) and control subjects (35% removal [27%, 39%]) (P=0.73). In RA, increasing net cholesterol efflux capacity was not significantly associated with decreased coronary calcium score (OR=0.78 (95% CI 0.51-1.19), P=0.24, adjusted for age, race and sex, Framingham risk score and presence of diabetes). Net cholesterol efflux capacity was not significantly associated with RA disease activity score, C-reactive protein, urinary F2-isoprostanes, or degree of insulin resistance in RA.
Conclusions: Net cholesterol efflux capacity is not significantly altered in patients with relatively well-controlled RA nor is it significantly associated with coronary artery calcium score.
Keywords: HDL; athero; cholesterol efflux; lipoprotein; rheumatoid arthritis.
Conflict of interest statement
Conflict of interest The authors report no relationships that could be construed as a conflict of interest.
Figures

Similar articles
-
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.Arthritis Rheumatol. 2016 Sep;68(9):2099-105. doi: 10.1002/art.39675. Arthritis Rheumatol. 2016. PMID: 26991245 Free PMC article.
-
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.Ann Rheum Dis. 2012 Jul;71(7):1157-62. doi: 10.1136/annrheumdis-2011-200493. Epub 2012 Jan 20. Ann Rheum Dis. 2012. PMID: 22267330 Free PMC article.
-
Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.Arthritis Care Res (Hoboken). 2010 Oct;62(10):1473-80. doi: 10.1002/acr.20237. Arthritis Care Res (Hoboken). 2010. PMID: 20506360 Free PMC article.
-
High-density lipoprotein function in rheumatoid arthritis.Curr Opin Lipidol. 2016 Feb;27(1):67-75. doi: 10.1097/MOL.0000000000000256. Curr Opin Lipidol. 2016. PMID: 26709471 Free PMC article. Review.
-
HDL-C: role as a risk modifier.Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6. Atheroscler Suppl. 2011. PMID: 22152280 Review.
Cited by
-
Exercise is Associated With Increased Small HDL Particle Concentration and Decreased Vascular Stiffness in Rheumatoid Arthritis.J Clin Rheumatol. 2018 Dec;24(8):417-421. doi: 10.1097/RHU.0000000000000809. J Clin Rheumatol. 2018. PMID: 29846271 Free PMC article.
-
A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis.Lipids Health Dis. 2021 Feb 21;20(1):18. doi: 10.1186/s12944-021-01444-6. Lipids Health Dis. 2021. PMID: 33612101 Free PMC article.
-
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects.J Clin Med. 2019 Aug 15;8(8):1225. doi: 10.3390/jcm8081225. J Clin Med. 2019. PMID: 31443207 Free PMC article.
-
Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.Arthritis Res Ther. 2024 Jun 24;26(1):123. doi: 10.1186/s13075-024-03352-3. Arthritis Res Ther. 2024. PMID: 38915065 Free PMC article. Clinical Trial.
-
Anti-Inflammatory Effect of High-Density Lipoprotein Blunted by Delivery of Altered MicroRNA Cargo in Patients With Rheumatoid Arthritis.Arthritis Rheumatol. 2024 May;76(5):684-695. doi: 10.1002/art.42782. Epub 2024 Jan 24. Arthritis Rheumatol. 2024. PMID: 38111131 Free PMC article.
References
-
- Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481–494. - PubMed
-
- Pincus T, Sokka T, Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum. 2001 Jun;44(6):1234–1236. - PubMed
-
- Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005 Oct;52(10):3045–3053. - PubMed
-
- Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials